{"disease":{"id":"leukaemia-myelocytic-acute","name":"leukaemia myelocytic acute"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02177812","title":"A Phase I Dose Escalation Study of GSK2879552 in Subjects With Acute Myeloid Leukemia (AML)","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":41,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00725283","title":"Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia (AML)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01428427","title":"Combination Study of GSK1120212 With Gemcitabine in Subjects With Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT01051063","title":"Evaluation of a New Anti-cancer Immunotherapy in Adult Acute Myeloid Leukemia Patients With a Suboptimal Clinical Response to Induction Chemotherapy","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"GlaxoSmithKline","has_results":true}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}